EXPERIMENTAL STUDIES
Signaling and expression for mitochondrial membrane proteins during left ventricular remodeling and contractile failure after myocardial infarction
Xue-Han Ning, MD* c,
Jianyi Zhang, MD, PhD c,
Jingbo Liu, MD, PhD c,
Yun Ye, MD c,
Shi-Han Chen, PhD* c,
Arthur H. L. From, MD c,
Robert J. Bache, MD, FACC c and
Michael A. Portman, MD, FACC* c
* Cardiology Division, Department of Pediatrics, University of Washington, Seattle, Washington, USA
Department of Medicine, University of Minnesota Health Sciences Center, Minneapolis, Minnesota, USA
c Department of Veterans Affairs Medical Center, Minneapolis, Minnesota, USA. %
Manuscript received June 25, 1999;
revised manuscript received January 17, 2000,
accepted March 6, 2000.
Reprint requests and correspondence: Michael A. Portman, Cardiology/CH11, Childrens Hospital and Regional Medical Center, 4800 Sand Point Way Northeast, Seattle, Washington 98105 mportm{at}chmc.org
OBJECTIVES
This study was conducted to test hypotheses stating that: 1) altered signaling for mitochondrial membrane proteins occurs during postinfarction remodeling, and 2) successful myocardial adaptation relates to promotion of specific mitochondrial membrane components.
BACKGROUND
Abnormalities in high-energy phosphate content and limitations in adenosine 5'-triphosphate (ATP) synthesis rate occur during the transition to contractile failure from compensatory remodeling after left ventricular infarction. The adenine nucleotide translocator (ANT) and F1-ATPase respectively regulate mitochondrial adenosine 5'-diphosphate (ADP)/ATP exchange and ADP-phosphorylation, which are key components of high-energy phosphate metabolism.
METHODS
Steady-state mRNA and protein expression for ANT isoform1 and the beta subunit of the F1-ATPase (betaF1) were analyzed in myocardium remote from the infarction zone eight weeks after left circumflex coronary artery ligation in pigs, demonstrating either successful left ventricular remodeling (LVR, n = 8) or congestive heart failure (CHF, n = 4) as determined by clinical and contractile performance parameters.
RESULTS
Substantial reductions in steady-state mRNA expression for ANT1 and betaF1 relative to normal (n = 8) occur in CHF, p < 0.01, but not in LVR. Relative expression for both proteins coordinated with their respective steady-state mRNA levels; CHF at 40% normal, p < 0.05 for ANT and 70% normal for betaF1, p < 0.05.
CONCLUSIONS
Maintained signaling for major mitochondrial membrane proteins occurs in association with successful remodeling and adaptation after infarction. Reduced expression of these proteins relates to limited ATP synthesis capacity and high energy phosphate kinetic abnormalities previously demonstrated in CHF. These findings imply that mitochondrial processes participate in myocardial remodeling after infarction.
|
Abbreviations and Acronyms
| | ADP | = adenosine 5'-diphosphate | | ANT | = adenine nucleotide translocator | | ATP | = adenosine 5'-triphosphate | | cDNA | = complementary DNA | | CHF | = congestive heart failure | | CK | = creatine kinase | | G3PDH | = glyceraldehol-3-phosphate dehydrogenese | | LCX | = left circumflex coronary artery | | LV | = left ventricle or ventricular | | LVR | = left ventricular remodeling | | SDS | = sodium dodecyl sulfate |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. Gundewar, J. W. Calvert, S. Jha, I. Toedt-Pingel, S. Yong Ji, D. Nunez, A. Ramachandran, M. Anaya-Cisneros, R. Tian, and D. J. Lefer
Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure
Circ. Res.,
February 13, 2009;
104(3):
403 - 411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Abozguia, T. T. Phan, G. N. Shivu, A. R. Maher, I. Ahmed, A. Wagenmakers, and M. P. Frenneaux
Reduced in vivo skeletal muscle oxygen consumption in patients with chronic heart failure--A study using Near Infrared Spectrophotometry (NIRS)
Eur J Heart Fail,
July 1, 2008;
10(7):
652 - 657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Neubauer
The Failing Heart -- An Engine Out of Fuel
N. Engl. J. Med.,
March 15, 2007;
356(11):
1140 - 1151.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Portman, K. Qian, J. Krueger, and X.-H. Ning
Direct action of T3 on phosphorylation potential in the sheep heart in vivo
Am J Physiol Heart Circ Physiol,
May 1, 2005;
288(5):
H2484 - H2490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ventura-Clapier, A. Garnier, and V. Veksler
Energy metabolism in heart failure
J. Physiol.,
February 15, 2004;
555(1):
1 - 13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gong, J. Liu, P. Liang, T. Guo, Q. Hu, K. Ochiai, M. Hou, Y. Ye, X. Wu, A. Mansoor, et al.
Oxidative capacity in failing hearts
Am J Physiol Heart Circ Physiol,
July 11, 2003;
285(2):
H541 - H548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-H. Ning, S.-H. Chen, C.-S. Xu, O. M. Hyyti, K. Qian, J. J. Krueger, and M. A. Portman
Hypothermia preserves myocardial function and mitochondrial protein gene expression during hypoxia
Am J Physiol Heart Circ Physiol,
June 5, 2003;
285(1):
H212 - H219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Park, J. Zhang, Y. Ye, S. Ormaza, P. Liang, A. J. Bank, L. W. Miller, and R. J. Bache
Myocardial creatine kinase expression after left ventricular assist device support
J. Am. Coll. Cardiol.,
June 5, 2002;
39(11):
1773 - 1779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu, C. Wang, Y. Murakami, G. Gong, Y. Ishibashi, C. Prody, K. Ochiai, R. J. Bache, C. Godinot, and J. Zhang
Mitochondrial ATPase and high-energy phosphates in failing hearts
Am J Physiol Heart Circ Physiol,
September 1, 2001;
281(3):
H1319 - H1326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ye, C. Wang, J. Zhang, Y. K. Cho, G. Gong, Y. Murakami, and R. J. Bache
Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy
Am J Physiol Heart Circ Physiol,
July 1, 2001;
281(1):
H376 - H386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Marin-Garcia, M. J Goldenthal, and G. W Moe
Mitochondrial pathology in cardiac failure
Cardiovasc Res,
January 1, 2001;
49(1):
17 - 26.
[Full Text]
[PDF]
|
 |
|
|